Connection
Andrew Bradford to Cyclin-Dependent Kinase Inhibitor p18
This is a "connection" page, showing publications Andrew Bradford has written about Cyclin-Dependent Kinase Inhibitor p18.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.184 |
|
|
|
-
Kurayoshi K, Okuno J, Ozono E, Iwanaga R, Bradford AP, Kugawa K, Araki K, Ohtani K. The phosphatidyl inositol 3 kinase pathway does not suppress activation of the ARF and BIM genes by deregulated E2F1 activity. Biochem Biophys Res Commun. 2017 Jan 22; 482(4):784-790.
Score: 0.147
-
Kurayoshi K, Shiromoto A, Ozono E, Iwanaga R, Bradford AP, Araki K, Ohtani K. Ectopic expression of the CDK inhibitor p21Cip1 enhances deregulated E2F activity and increases cancer cell-specific cytotoxic gene expression mediated by the ARF tumor suppressor promoter. Biochem Biophys Res Commun. 2017 01 29; 483(1):107-114.
Score: 0.037